Fauci says he expects J&J vaccine to resume ‘by Friday’

America is likely to resume Johnson & Johnson COVID vaccine, with restrictions to counteract rare blood clots, says Dr. Fauci.

  • President Biden’s chief medical adviser said shots would return with restrictions
  • Would be ‘very surprised if J&J vaccine does not’ resume in shape by Friday ‘
  • There have been six blood clots from more than 7 million US vaccinations

The U.S. is likely to resume Johnson & Johnson’s COVID-19 vaccine next week, possibly with restrictions or broader warnings following reports of very rare cases of blood clots, the government’s leading expert in infectious diseases said on Sunday.

Dr. Anthony Fauci, in a series of interviews on the news program, said he expects a decision when advisers from the Centers for Disease Control and Prevention meet on Friday to discuss the suspension of J & J’s single-dose vaccine.

“I would be very surprised if we did not resume in some form by Friday,” he said. “I do not really expect them to stretch it any longer.”

Dr Anthony Fauci, in a series of interviews with news programs, said he expects a decision when advisers from the Centers for Disease Control and Prevention meet on Friday to discuss the discontinuation of J & J's single-dose vaccine.

Dr Anthony Fauci, in a series of interviews with news programs, said he expects a decision when advisers from the Centers for Disease Control and Prevention meet on Friday to discuss the discontinuation of J & J’s single-dose vaccine.

Fauci, who is President Joe Biden’s chief medical adviser, said he believes federal regulators can return the shots with age or gender restrictions or with a warning, so in a way ‘administered a little differently’ word. than we were before the break. ‘

The J&J vaccine was in limbo after the CDC and the Food and Drug Administration said last week that they needed more evidence to decide whether a handful of unusual blood clots were linked to the shot – and if so, how big the risk was. is.

The reports are rare – six cases out of more than 7 million US vaccines with J&J vaccine. The blood clots were found in six women between the ages of 18 and 48. One person is dead.

The acting FDA commissioner said she expected the break to last only a few days. Yet the decision last Tuesday caused a swift action in Europe and elsewhere.

Fauci said he had serious doubts that the US would permanently discontinue use of the J&J vaccine.

The boxes are on the following bottles of Johnson & Johnson COVID-19 vaccine at the National Jewish Hospital's pharmacy for distribution in Denver.  Picture taken in March

The boxes are on the following bottles of Johnson & Johnson COVID-19 vaccine at the National Jewish Hospital’s pharmacy for distribution in Denver. Picture taken in March

“I do not think it will happen,” he said. ‘The pause was to take a look, make sure we know all the information we can have within that timing and also warn some doctors that people, especially women, who have this particular side effect are seeing what they treat. them properly. ‘

“I think it would probably say, ‘OK, we’m going to use it. However, be careful under these certain circumstances. ‘

More than 6.8 million doses of the J&J vaccine have been given in the US, the vast majority with no or mild side effects. Authorities stressed that they found no evidence of clotting problems with the most widely used COVID-19 vaccines in the US – from Moderna and Pfizer.

Fauci appeared on NBC’s’ Meet the Press’, ‘CNN’s State of the Union,’ ABC’s’ This Week ‘and CBS’ ‘Face the Nation’.

.Source